Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Releases Draft Guidance on Use of Remote Regulatory Assessments

The guidance covers voluntary and statutorily authorized RRAs, but does not change the core requirements of inspections and pre- and post-market authorities.

Fda Logo, Hi Res

The FDA has released a draft guidance on the expanded use of remote regulatory assessments (RRAs) and how it intends them to be incorporated consistently across all FDA-regulated products. The remote assessments of FDA-regulated establishments and/or their records can help determine compliance with applicable FDA requirements, inform regulatory decisions, and verify information submitted to the agency.

The draft guidance, “Conducting Remote Regulatory Assessments Questions and Answers,” provides transparency to stakeholders about how RRAs may be used and to promote consistency in the way they are conducted. It covers voluntary and statutorily authorized RRAs, but does not change the core requirements of inspections and pre- and post-market authorities. Except for RRAs for establishments required to comply with the Foreign Supplier Verification Programs (FSVP) regulation, an RRA does not function as an inspection.


Read article   Emerging EU Sustainability Regulations for Packaging


The FDA will continue to use RRAs, as appropriate, according to a risk-based approach that best protects public health, such as when it is unable to deploy in-person staff due to travel restrictions. RRAs may also be used to assess establishments identified in product applications when these establishments have a prior history of compliance. Where appropriate, RRAs allow the FDA to review information, such as livestreams and records, provided by a company without going on-site.

As part of the FDA’s Fiscal Year 2023 budget request, the agency has requested additional authorities to expand the ability to use remote regulatory tools across all commodities. The agency currently relies on voluntary cooperation for the use of these tools for non-drug establishments or when the RRA does not involve assessing a food importer’s compliance with FSVP.


 


Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging